Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medicure (MCUJF) Interest Expenses (2016 - 2025)

Medicure has reported Interest Expenses over the past 17 years, most recently at $5.0 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 75.92% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $13.4 million, up 15.49%, while the annual FY2025 figure was $13.4 million, 17.96% up from the prior year.
  • Interest Expenses for Q4 2025 was $5.0 million at Medicure, up from $3.0 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $5.0 million in Q4 2025 and troughed at $2.3 million in Q3 2022.
  • A 5-year average of $3.0 million and a median of $2.9 million in 2022 define the central range for Interest Expenses.
  • On a YoY basis, Interest Expenses climbed as much as 133.76% in 2021 and fell as far as 24.77% in 2021.
  • Year by year, Interest Expenses stood at $2.7 million in 2021, then rose by 5.66% to $2.9 million in 2022, then increased by 0.54% to $2.9 million in 2023, then decreased by 3.06% to $2.8 million in 2024, then soared by 75.92% to $5.0 million in 2025.
  • Business Quant data shows Interest Expenses for MCUJF at $5.0 million in Q4 2025, $3.0 million in Q3 2025, and $3.0 million in Q2 2025.